Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in 2 Salivary Gland Tumors

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Turkish Journal of Pathology Turkish association of Pathology Volume:
Keywords : Diagnostic Utility , Immunohistochemical Expressions , IMP3 Versus    
Abstract:
Objective: The diverse site of origin and classification complexity of salivary glands tumors increase difficulties in their diagnosis. This study aimed to evaluate the specificity and diagnostic ability of immunohistochemical expressions of IMP3 versus DOG1 and p63 in cases of such tumors. Material and Method: Thirty paraffin-embedded salivary gland tumors were obtained from the Pathology Department Archive. Their diagnosis was confirmed. The specimens were then re-classified and evaluated using the IMP3, DOG1 and p63 immunohistochemical markers. Results: There were 8 pleomorphic adenoma (PA), 12 mucoepidermoid carcinoma (MEC) and 10 adenoid cystic carcinoma (ADC) cases. All 12 MECs (100%) were IMP3 positive, while 30% of ADCs and only 25% of PAs were positive for IMP3. There was a statistically significant relationship between salivary gland tumors and IMP3 immunostaining (P =0.03). As regards to DOG1 results, 12.5% of PAs showed variable luminal positive immunostaining and 40% of ADCs showed weak luminal and abluminal immunostaining while 16.7% of MEC showed cytoplasmic staining. On the other hand, all ADCs (100%) showed moderate p63 reactivity in the nuclei of abluminal cells. All MEC cases (100%) were also p63-positive, showing a strong diffuse nuclear reactivity. A statistically significant relationship was noticed between salivary gland tumors and p63 immunostaining (P <0.05). Conclusion: IMP3 is more sensitive for diagnosis of MEC than ADC. p63 is statistically significant in diagnosing salivary gland tumors (MEC and ADC). On the other hand, DOG1 staining is not sensitive in diagnosis of studied malignant salivary gland tumors, limiting its diagnostic utility.
   
     
 
       

Author Related Publications

  • Mona Mostafa Ahmed Muhamd, "Expression of immunomodulator programmed death ligand 1 and fork head box protein 3 in squamous cell carcinoma of cervix", Egyptian Journal of Pathology, 2018 More
  • Mona Mostafa Ahmed Muhamd, "INFLUENCE OF SELENIUM ON MONO SODIUM GLUTAMATE AS FOOD ADDITIVE INDUCED HEPATOTOXICITY AND TESTICULAR TOXICITY IN ADULT ALBINO RATS", ypt J. Forensic Sci. Appli. Toxicol, 2018 More
  • Mona Mostafa Ahmed Muhamd, "ENHANCER OF ZESTE HOMOLOG 2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR IMMUNOHISTOCHEMICAL EXPRESSION ARE ASSOCIATED WITH ADVERSE CLINICAL OUTCOME IN NON-METASTATIC CLEAR CELL RENAL CELL CARCINOMA.", Int. J. Adv. Res, 2017 More
  • Mona Mostafa Ahmed Muhamd, "Expression of enhancer of zeste homolog 2 and cytokeratin 5/6 in triple negative versus non-triple negative breast cancer: An immunohistochemical study.", International Journal of Advanced Research, 2016 More
  • Mona Mostafa Ahmed Muhamd, "Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors", Turkish Journal of Pathology, 2020 More

Department Related Publications

  • Aziza Alsayed Abdelrahman, "Prognostic Value of Twist-1, E-cadherin and EZH2 in Prostate Cancer: An Immunohistochemical Study", Federation of Turkish pathology socities, 2017 More
  • Naglaa Ali Mostafa Ramadan, "Prognostic Significance of CXCR4 and mTOR expression in diffuse large B-cell lymphoma patients", sciedu press, 2019 More
  • Ola Abdelrahman Youssef, "Co-expression of epithelial mesenchymal transition markers NEDD9 and Twist1 in carcinoma of the uterine cervix and their clinical significances", Edorium J Pathol 2017;4:1–13., 2017 More
  • Annan Fathy Mohamed AbdelAal, "Validity of SATB2 in distinguishing metastatic mucinous carcinoma of colorectal origin from primary ovarian mucinous carcinoma", lippincott Williams&Wilkins, 2018 More
  • Tayseer Refaat Ibrahim Elsayed, "Clinicopathological and Prognostic Value of Immunohistochemical Expression of CD44 (Stem Cell Marker) and Ki67 in Serous Ovarian Cancer", india, 2020 More
Tweet